PT101310A - Antigenio sob a forma de particulas e processo para a preparacao de particulas semelhantes a virus ou de particulas semelhantes a nucleos de virus - Google Patents

Antigenio sob a forma de particulas e processo para a preparacao de particulas semelhantes a virus ou de particulas semelhantes a nucleos de virus

Info

Publication number
PT101310A
PT101310A PT101310A PT10131093A PT101310A PT 101310 A PT101310 A PT 101310A PT 101310 A PT101310 A PT 101310A PT 10131093 A PT10131093 A PT 10131093A PT 101310 A PT101310 A PT 101310A
Authority
PT
Portugal
Prior art keywords
particles
similar
viruses
antigen
preparation
Prior art date
Application number
PT101310A
Other languages
English (en)
Portuguese (pt)
Inventor
Polly Roy
Original Assignee
Oxford University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929215101A external-priority patent/GB9215101D0/en
Application filed by Oxford University filed Critical Oxford University
Publication of PT101310A publication Critical patent/PT101310A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Clostridium (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
    • C07K2319/23—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a GST-tag
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12111—Orbivirus, e.g. bluetongue virus
    • C12N2720/12122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10123—Virus like particles [VLP]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
    • C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT101310A 1992-07-16 1993-07-16 Antigenio sob a forma de particulas e processo para a preparacao de particulas semelhantes a virus ou de particulas semelhantes a nucleos de virus PT101310A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929215101A GB9215101D0 (en) 1992-07-16 1992-07-16 Multiple particulate antigen delivery system
US97115892A 1992-11-04 1992-11-04

Publications (1)

Publication Number Publication Date
PT101310A true PT101310A (pt) 1994-05-31

Family

ID=26301262

Family Applications (1)

Application Number Title Priority Date Filing Date
PT101310A PT101310A (pt) 1992-07-16 1993-07-16 Antigenio sob a forma de particulas e processo para a preparacao de particulas semelhantes a virus ou de particulas semelhantes a nucleos de virus

Country Status (6)

Country Link
CN (1) CN1084218A (he)
AU (1) AU4773293A (he)
IL (1) IL106362A (he)
MX (1) MX9304310A (he)
PT (1) PT101310A (he)
WO (1) WO1994002173A1 (he)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ312502A (en) * 1995-07-07 1999-03-29 Oravax Inc Clostridium difficile toxins as mucosal adjuvants
US5919463A (en) * 1995-07-07 1999-07-06 Oravax, Inc. Clostridium difficle toxins as mucosal adjuvants
WO1997002835A1 (en) * 1995-07-07 1997-01-30 Oravax, Inc. Intranasal vaccination against gastrointestinal disease
US7476517B2 (en) 1999-06-30 2009-01-13 Evotec Ag Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
JP2003504014A (ja) * 1999-06-30 2003-02-04 エボテック オーアーイー アクチェンゲゼルシャフト ウイルス状粒子、それらの調製及び好ましくは薬学的スクリーニング及び機能的ゲノムにおけるそれらの使用
US20040014033A1 (en) 1999-06-30 2004-01-22 Evotec Biosystems Ag, A Corporation Of Germany Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
EP1219705B1 (en) * 2000-12-29 2007-11-28 Evotec AG Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
US11053509B2 (en) 2016-04-19 2021-07-06 Csir Plant-produced chimaeric Orbivirus VLPs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4722840A (en) * 1984-09-12 1988-02-02 Chiron Corporation Hybrid particle immunogens

Also Published As

Publication number Publication date
CN1084218A (zh) 1994-03-23
WO1994002173A1 (en) 1994-02-03
AU4773293A (en) 1994-02-14
IL106362A0 (en) 1993-11-15
MX9304310A (es) 1995-01-31
IL106362A (he) 1998-12-06

Similar Documents

Publication Publication Date Title
BR9200864A (pt) Corpos abrasivo aglutinado,particulas abrasivas aluminosas e processo para sua producao,processo para melhorar o desempenho de esmerilhamento de corpo abrasivo e particolas de po abrasivo aluminoso
BR9606992A (pt) Processo para o uso na construção de uma roupa e sistema de processamento
BR9710105A (pt) Processo para a preparação de particulas políméricas e artigos esponjados
BR9612314A (pt) Composição particulada e processo para a produção de partículas
KR920700060A (ko) 공중 입자를 제거 및 회수하기 위한 싸이클로닉 분리기
BR9000198A (pt) Processo de preparacao de particulas e particulas obtidas
BR9302494A (pt) Processo e dispositivo para a fabricacao de filtros dobrados em zigue-zague
BR8707905A (pt) Sistema de vaporizacao de e processo para aplicar material em particulas
BR9007399A (pt) Composicao,processo para sua preparacao,processo para preparacao de particulas fibrosas e particulas fibrosas
BR9207026A (pt) Aparelho e processo para separação de partículas úmidas
IT1188182B (it) Titanati in forma di particelle sferiche e processo per la loro preparazione
PT101310A (pt) Antigenio sob a forma de particulas e processo para a preparacao de particulas semelhantes a virus ou de particulas semelhantes a nucleos de virus
BR8606831A (pt) Processo para a recuperacao de metal e composicoes utilizaveis no mesmo
BR9504387A (pt) Composto processo para sua preparaçao processo para intensificar o fator de proteçao solar de materiais e uso
BR9006776A (pt) Produto para o tratamento dos cabelos na forma de espuma e processo para a sua preparacao
FR2587989B1 (fr) Compositions particulaires d'oxalates de metaux ferromagnetiques, sous forme de particules aciculaires submicroniques, leur preparation et leur application
BR9000155A (pt) Processo para a preparacao de um material em particulas de baixa densidade e substancialmente insoluvel em agua e material assim preparado
BR9101089A (pt) Explosivo em emulsao de agua em oleo e processo para formar o mesmo
MX21387A (es) Compuesto y metodo para mejorar la dispersabilidad de particulas micaceas.
BR9000197A (pt) Processo de preparacao de particulas nao colantes e particulas obtidas
AU1631188A (en) Newcastle disease virus vaccine and method for the application thereof
BR9007230A (pt) Processo para a preparacao de derivados de guanina 9-substituida e intermediarios para uso no processo
BR9201934A (pt) Processo para separar particulas minerais relativamente magneticas
PT89495A (pt) Processo para o reforco estrutural de produtos manufacturados frageis de pedra ou aglomerados em geral e produtos assim obtidos
BR9301705A (pt) Composicoes fungicidas em particulas e processo de sua producao

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19931018

FC3A Refusal

Effective date: 19991202